Innovation Health and Sanofi (NYSE:SNY) said today that the companies are launching a pilot program to evaluate the impact of digital health solutions from One Drop and Common Sensing for people with Type II diabetes.
The program hopes to enable pharmaceutical companies, tech companies and plan providers to work together to improve patient outcomes, according to Innovation Health.
Get the full story at our sister site, Drug Delivery Business News.
The post Sanofi, Innovation Health to evaluate digital health solutions for Type II diabetes appeared first on MassDevice.